Clinical Trial Update: Safety Study of INX-08189, Pharmacokinetic and Pharmacodynamic With Ribavirin and Food Effect Study, in Chronically-infected Genotype 1 Hepatitis C Virus, Treatment-naïve Subjects [Phase 1, Phase 2]

View source ↗

Summary

This ClinicalTrials.gov entry reports a Phase 1/2 safety, pharmacokinetic, and pharmacodynamic study of INX-08189 with ribavirin in treatment-naïve patients wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• INX-08189
• Ribavirin (ribavirin)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Hepatitis C | Phase 1, Phase 2 | Status: COMPLETED